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Summary
Hereditary spastic paraplegias (HSPs), a group of
neurodegenerative disorders characterized by lower-
extremity spasticity and weakness, are most com-
monly caused by mutations in the spastin gene,
which encodes a AAA+ ATPase [1, 2] related to the
microtubule-severing protein katanin [3]. A Drosoph-
ila homolog of spastin (D-spastin) was identified re-
cently [4], and D-spastin RNAi-treated or genetic null
flies show neurological defects, and protein over-
expression decreases the density of cellular micro-
tubules [5, 6]. Elucidating spastin’s function and
disease mechanism will require a more detailed un-
derstanding of its structure and biochemical mecha-
nism. Here, we have investigated the effects of
D-spastin, individual D-spastin domains, and D-spas-
tin proteins bearing disease mutations on microtu-
bules in cellular and in vitro assays. We show that
D-spastin, like katanin, displays ATPase activity and
uses energy from ATP hydrolysis to sever and disas-
semble microtubules; disease mutations abolish or
partially interfere with these activities.
Results and Discussion
Localization and Effects on Microtubules
of D-spastin Expressed in Drosophila S2 Cells
We first cloned D-spastin from a Drosophila Schneider
(S2) cell cDNA library, fused GFP to its C terminus, and
expressed it in S2 cells in order to establish its subcel-
lular distribution and in vivo activity (Figures 1 and 2).
Previous localization studies of mammalian spastin
have yielded diverse and often conflicting results, in-
cluding nuclear localization [7], a mixture of nuclear and
cytoplasmic distributions [8–10], and endosomal local-
ization [11]. At low expression levels, we found that
D-spastin-GFP was localized to discrete punctate
structures that were distributed throughout the cyto-
plasm, suggestive of membrane vesicle association
(Figure 2, first panel). Strikingly, cells expressing even
relatively low levels of D-spastin-GFP showed dimin-
ished microtubule staining and many small microtubule
fragments. Cells expressing higher levels of D-spastin-
GFP displayed a nearly complete absence of cyto-
plasmic microtubules (not shown). These results are
consistent with previous studies showing that spastin
overexpression results in microtubule disassembly [5,*Correspondence: vale@cmp.ucsf.edu6, 12–14] and with a recent report showing that spastin
is targeted to membrane vesicles [11].
Spastins are composed of three domains: an N-ter-
minal region containing a putative transmembrane-
spanning sequence (TM), a microtubule interacting and
trafficking (MIT) domain that is well conserved in the
spastin family, and an ATP binding AAA domain (AAA)
(Figure 1). Because the functions of these domains re-
main poorly understood, we expressed various trun-
cated D-spastin-GFP constructs in S2 cells (Figure 2).
A construct lacking the transmembrane-containing N
terminus (TM D-spastin-GFP) was diffusely distrib-
uted in the cytoplasm, indicating that the TM domain is
required for the vesicular staining pattern observed for
the full-length construct. TM D-spastin-GFP was fully
active for disassembling cytoplasmic microtubules (Fig-
ure 2). In contrast, a construct that lacked the AAA do-
main (TM + MIT) still localized to punctate structures
but did not affect the microtubule cytoskeleton. The
MIT or AAA domains alone were diffusely localized and
did not disassemble microtubules. Immunoblot analy-
sis confirmed that these GFP fusion constructs ex-
pressed intact proteins (see Figure S1 in the Supple-
mental Data available with this article online). These
results indicate that the TM/MIT region is involved in
membrane targeting and the MIT/AAA region has activ-
ity on the microtubule cytoskeleton.
Recombinant D-spastin Severs and Disassembles
Microtubules In Vitro
The cellular expression studies described above and
those by others do not prove that spastin is a microtu-
bule disassembly agent because such effects might be
indirect or require additional cellular cofactors. We
therefore tested whether purified D-spastin is capable
of microtubule disassembly in vitro. D-Spastin lacking
the TM region was expressed in E. coli as a GST fusion
protein and was purified to higher than 95% homo-
geneity (Figure 3A, left panel). We tested the purified
D-spastin for ATPase activity and found that it hy-
drolyzed 1.8 ATP/subunit/s (Figure 3A, right panel),
which is similar to the maximal microtubule-stimulated
ATPase rate reported for katanin [15]. Thus far, we have
not observed a stimulation of the ATPase rate by taxol-
stabilized microtubules. When purified D-spastin and
ATP were applied to taxol-stabilized, rhodamine-labeled
microtubules bound to a glass surface, the microtu-
bules were completely disassembled after 2 min (Figure
3B; Movie S1). At earlier time points, microtubules de-
veloped discrete breaks along their length. We also ob-
served severing of non-taxol-stabilized microtubules
when D-spastin was added to interphase Xenopus ex-
tracts containing self-assembled microtubules (not
shown). Thus, like katanin [16], D-spastin is capable of
severing microtubules. The microtubule-severing reac-
tion required ATP hydrolysis because microtubules re-
mained intact if ATP was omitted from the reaction (Fig-
ure 3B, upper panel) or if the nonhydrolyzable ATP
analog ATPγS was added instead of ATP (not shown).
Microtubules became resistant to spastin-mediated
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651Figure 1. Domain Structure of Spastin
The following abbreviations were used: TM, putative transmembrane region; MIT, microtubule interacting and trafficking domain; and AAA,
AAA+ ATPase domain. The positions of disease mutations (S462C, K488R [Walker A motif], E542A [Walker B motif], and D655N) are shown.
The precise boundaries of the constructs used in this study are indicated in the Supplemental Experimental Procedures.severing when the negatively charged C-terminal pep-
tide of tubulin was cleaved by subtilisin digestion (Fig-
ure S2). Subtilisin-treated microtubules are also resis-
tant to severing by katanin [16].
These experiments demonstrate that D-spastin alone
can couple ATP hydrolysis to microtubule disassembly,
and they confirm our cellular results that the MIT-AAA
region is sufficient for this activity. Errico and col-
leagues [8] reported that the N-terminal TM region in
human spastin is crucial for microtubule binding be-
cause truncated spastin lacking this region did not
cosediment with microtubules. Although it remains pos-
sible that the TM region contributes to MT binding affin-
ity, our data show that the N terminus of D-spastin is
not required for microtubule binding and severing.
We also attempted to express full-length spastin and
the AAA domain in bacteria but found that they were
unstable and formed large aggregates. However, the
MIT domain could be expressed and purified. This do-
main did not sever microtubules, and in cosedimenta-
tion binding experiments, it bound to microtubules
much more weakly (Kd = 27 M) than the TM con-
struct (Kd < 1 M) in the absence of nucleotide. The
lack of high-affinity binding is consistent with our find-
ing that the MIT domain expressed in S2 cells did not
colocalize with microtubules (Figure 2). Thus, high-
affinity microtubule binding appears to require the com-
bination of the MIT and the AAA domain or at least ad-
ditional sequence beyond the minimal conserved-MIT
domain investigated in this study.
Activity of D-Spastin Mutants That Give Rise
to Disease Phenotypes
More than 140 spastin gene mutations have been iso-
lated from HSP patients. Nonsense, frameshift, or splice
site mutations are mostly scattered throughout the
gene, whereas missense mutations are located almost
exclusively in the AAA domain, underscoring the impor-tance of this ATP binding module for spastin’s function.
The 28 known missense mutations provide an array of
tools with which to probe spastin’s function. We de-
cided to examine three such mutations: a critical
Walker A residue (K488R) that is predicted to impair
ATP binding and mutations situated at the N- (S462C)
and C-terminal (D655N) ends of the AAA domain [17]
(Figure 1). On the basis of structure-based sequence
alignments, D655 resides in the C-terminal helical sub-
domain of the AAA module that contributes to nucleo-
tide-dependent conformational changes [18]. In addition
to these known disease mutations, we also investi-
gated a mutation in a key Walker B residue (E542A)
known to be involved in ATP hydrolysis in other AAA+
ATPases.
When full-length (FL) D-spastin constructs harboring
these mutations were expressed in S2 cells, we found
that they localized to distinct punctate structures, as
seen with wild-type D-spastin. However, for the Walker
A (K488R) and Walker B (E542A) mutants, microtubule
disassembly was not observed; instead, at moderate to
high expression levels, microtubule bundling was ob-
served around the perinuclear region (Figure 4). Sur-
prisingly, the S462C and D655N mutants still severed
microtubules when transfected into cells, although their
activity was not as robust as wild-type D-spastin (Fig-
ure 4) because higher levels of expression appear to be
needed to disrupt the microtubule network. This result
differs from a study showing that expression of the
equivalent serine-to-cysteine human disease mutant
did not cause microtubule destabilization [11].
In the TM constructs, the Walker A and B site mu-
tants showed very different subcellular localizations. At
low expression levels, the ATP-binding-deficient mu-
tant K488R was diffusely distributed, and at high levels
it coated and bundled microtubules (Figure 4). In con-
trast, the ATP-hydrolysis-deficient mutant E542A colo-
calized with and bundled only a subset of microtubules,
perhaps suggestive of cooperative binding or binding
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652Figure 2. In Vivo Distribution and Microtu-
bule-Destabilizing Activity of D-spastin and
Its Domains
Constructs indicated on the left correspond
to those shown in Figure 1. Cells were fixed
and stained with anti-α tubulin antibodies
(red) and Hoechst 33342 (DNA; blue). The
distribution of GFP-spastin is shown in the
green channel. Microtubule destabilization is
evident in the transfected cells expressing
full-length (FL) and TM constructs. The
scale bar represents 5 M.to a specific subpopulation of microtubules. As noted g
afor the full-length constructs, the expressed TM
S462C and D655N mutant proteins also caused partial f
umicrotubule disassembly.
We also studied the biochemical activities of purified m
dD-spastin mutant proteins. The Walker A and B muta-
tions, as expected, displayed neither detectable ATPase b
activity nor in vitro microtubule-severing activity (Fig-
ures 3A and 3C). In contrast, the S462C and D655N C
Imutant proteins both showed ATPase activity but were
40% and 80% decreased in maximal activity when s
rcompared with the wild-type protein (Figure 3A). Sur-
prisingly, the S462C and D655N mutants displayed a s
tgreater impairment in severing taxol-stabilized microtu-
bules than might be expected on the basis of their o
AATPase activities. Whereas wild-type spastin almost
completely disassembled taxol-stabilized microtubules p
ron a surface within 2 min, the S462C mutant proteinenerated a comparable degree of disassembly only
fter >10 min, and the D655N mutant only generated a
ew microtubule breaks after a 20 min incubation (Fig-
re 3C). These data suggest that the S462C and D655N
utations impair ATPase activity but also produce a
efect in the coupling of ATPase activity to microtu-
ule destabilization.
omparison of Spastin and Katanin
n summary, we show that D-spastin severs and disas-
embles microtubules both in cells and in vitro. These
esults provide the first direct biochemical evidence of
pastin’s ATPase and microtubule-destabilizing activi-
ies. It is interesting to compare spastin to katanin, an-
ther AAA+ ATPase that severs microtubules. Spastin’s
AA domain is highly homologous to katanin, yet these
roteins share no sequence similarity in their N-terminal
egions. Thus, spastin and katanin appear to have
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653Figure 3. ATPase and Microtubule-Severing
Activities of Purified D-spastin In Vitro
(A) Left panel: Coomassie-stained gel of
purified GST-D-spastin (TM construct) (left
lane, molecular mass standards; right lane,
GST-D-spastin). Right panel: ATPase activity
of GST-D-spastin and D-spastin mutants
(TM construct). ATPase rates (see Supple-
mental Experimental Procedures) shown
were derived from four measurements (mean
and standard deviation).
(B) Severing and disassembly of purified
microtubules by D-spastin. Recombinant
GST-D-spastin (0.5 M) was introduced to
taxol-stabilized, rhodamine-labeled microtu-
bules adsorbed onto the surface of a micro-
scope perfusion chamber in the presence or
absence of 1 mM ATP. Arrows indicate
breaks in the microtubule.
(C) A similar experiment was performed for
GST-D-spastin mutants (0.5 M). The time
elapsed after perfusion onto the microtu-
bules is shown. The scale bar represents
5 m.evolved distinct microtubule binding domains that
communicate with a similar motor module to bring
about the severing reaction. Unlike katanin, which ap-
pears to be largely soluble or centrosome associated,
spastin appears to associate with vesicular membranesthrough its N-terminal domain containing a predicted
transmembrane-spanning sequence. This raises the
possibility that spastin may be involved in remodeling
the microtubule cytoskeleton near membrane surfaces,
which may be important for spastin’s function in synap-
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654Figure 4. Distribution of D-spastin Mutants in S2 Cells and Effects on Microtubules
S2 cells expressing C-terminally GFP-tagged full-length (FL) D-spastin or D-spastin lacking the TM region (TM) and harboring the indicated
mutations. Cells expressing low levels and high levels of these constructs are shown. The S462C and D655N mutants caused microtubule
disassembly at higher expression levels. Green, GFP-spastin; red, microtubules; and blue, DNA. Cells were fixed and stained as in Figure 2.
The scale bar represents 5 M.ftic architecture and transmission [5, 6]. Further investi-
Hgations linking spastin’s enzymatic activity to its cellu-
alar function will be required to better understand spastin’s
D
role in the nervous system as well as the mechanism i
by which spastin mutations give rise to the pathology F
of hereditary spastic paraplegias.
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